Ingrid Hoos

General Counsel at ETON PHARMACEUTICALS, INC.

Health Technology

Consumer Services

Profile

Ingrid Hoos is currently working as the Senior Vice President of Regulatory Affairs at Eton Pharmaceuticals, Inc. She previously held the position of VP of Regulatory Affairs & Regulatory Compliance at Horizon Pharma, Inc. and worked in Regulatory Affairs at Baxter Healthcare, Inc. In terms of education, Ms. Hoos completed her undergraduate degree at Northeastern Illinois University.

Ingrid Hoos active positions

Companies	Position	Start
ETON PHARMACEUTICALS, INC.	General Counsel	-

All active positions of Ingrid Hoos

Former positions of Ingrid Hoos

Companies	Position	End
Baxter Healthcare, Inc.	Corporate Officer/Principal	-
Horizon Pharma, Inc. Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL.	General Counsel	-

See the detail of Ingrid Hoos's experience

Training of Ingrid Hoos

Northeastern Illinois University

Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Ingrid Hoos's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies	1
ETON PHARMACEUTICALS, INC.	Health Technology

Private companies	2
Horizon Pharma, Inc. Horizon Pharma, Inc. Pharmaceuticals: MajorHealth Technology Horizon Pharma, Inc. discovers and develops medicines for the treatment of chronic inflammatory diseases. It is a specialty pharmaceutical company that has developed and is commercializing DUEXIS and RAYOS, both of which target unmet therapeutic needs in arthritis, pain and inflammatory diseases. The company products include DUEXIS (ibuprofen and famotidine) Tablets, is a proprietary, single-tablet combination of the non-steroidal anti-inflammatory drug ibuprofen and the histamine H2-receptor antagonist famotidine; RAYOS (prednisone) delayed-release tablets, known as LODOTRA outside the U.S., is a proprietary delayed-release formulation of low-dose prednisone for the treatment of moderate to severe, active RA in adults, particularly when accompanied by morning stiffness. Horizon Pharma was founded on March 23, 2010 and is headquartered in Deerfield, IL.	Health Technology
Baxter Healthcare, Inc.